Erva Ozkan

Years Active: 2020-2024
Publications (10 Years): 5

Ankara University Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Ankara University Faculty of Pharmacy Sep 18 2017

Turkey

PHD :: Biochemistry

Publications

Selen Gozde Kaya, Gokcen Eren, Alberto Massarotti, Filiz Bakar-Ates, Erva Ozkan, Mahmut Gozelle, Yesim Ozkan
2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition. Drug development research 85 (4) (2024)
Selen Gozde Kaya, Gokcen Eren, Alberto Massarotti, Filiz Bakar-Ates, Erva Ozkan, Mahmut Gozelle, Yesim Ozkan
2-(Methyl(phenyl)amino)-N-(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition. Drug development research 85 (4) (2024)
Erva Ozkan, Filiz Bakar-Ates
Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma. Journal of cancer research and clinical oncology (2023)
Filiz Bakar-Ates, Erva Ozkan
Atorvastatin induces downregulation of matrix metalloproteinase-2/9 in MDA-MB-231 triple negative breast cancer cells. Medical oncology (Northwood, London, England) 40 (1) (2022)
Erva Ozkan, Filiz Bakar-Ates
Potentiation of the Effect of Lonidamine by Quercetin in MCF-7 human breast cancer cells through downregulation of MMP-2/9 mRNA Expression. Anais da Academia Brasileira de Ciencias 92 (4) (2020)

Erva Ozkan.css-eqlu8i{font-size:small;padding-left:4px;}